PS20: Advancements in Medicine Development Through Artificial Intelligence: Current Status and Future Directions

Artificial Intelligence (AI) has been revolutionizing human society, and its full impact is yet to be fully realized. In the realm of medicine development, particularly within regulatory decision-making, the potential power of AI is undeniable. However, scientists, including biostatisticians, are still exploring methodologies and applications, preparing for the widespread adoption of AI at a mass production level. In this session, speakers from industry, academia, and the FDA will share their recent experiences with adopting AI in their daily work. They will provide insights on how the community can better prepare for the full adoption of AI in medicine development.